Format
Sort by

Send to

Choose Destination

Selected items

Items: 20

1.

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T.

Sleep. 2011 Oct 1;34(10):1433-42. doi: 10.5665/SLEEP.1294.

3.

Quality Indicators in Laboratory Medicine: from theory to practice. Preliminary data from the IFCC Working Group Project "Laboratory Errors and Patient Safety".

Sciacovelli L, O'Kane M, Skaik YA, Caciagli P, Pellegrini C, Da Rin G, Ivanov A, Ghys T, Plebani M; IFCC WG-LEPS.

Clin Chem Lab Med. 2011 May;49(5):835-44. doi: 10.1515/CCLM.2011.128. Epub 2011 Feb 23.

PMID:
21342024
4.

Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research.

Dropulić B.

Hum Gene Ther. 2011 Jun;22(6):649-57. doi: 10.1089/hum.2011.058. Epub 2011 May 19. Review.

PMID:
21486177
5.

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.

Sleep. 2010 Nov;33(11):1553-61.

6.

The IFCC Working Group on laboratory errors and patient safety.

Sciacovelli L, Plebani M.

Clin Chim Acta. 2009 Jun;404(1):79-85. doi: 10.1016/j.cca.2009.03.025. Epub 2009 Mar 26.

PMID:
19328194
7.

Errors in laboratory medicine: practical lessons to improve patient safety.

Howanitz PJ.

Arch Pathol Lab Med. 2005 Oct;129(10):1252-61.

PMID:
16196513
8.

Errors in laboratory medicine and patient safety: the road ahead.

Plebani M.

Clin Chem Lab Med. 2007;45(6):700-7. Review.

PMID:
17579520
9.

A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteins.

Thomas K, Aalbers M, Bannon GA, Bartels M, Dearman RJ, Esdaile DJ, Fu TJ, Glatt CM, Hadfield N, Hatzos C, Hefle SL, Heylings JR, Goodman RE, Henry B, Herouet C, Holsapple M, Ladics GS, Landry TD, MacIntosh SC, Rice EA, Privalle LS, Steiner HY, Teshima R, Van Ree R, Woolhiser M, Zawodny J.

Regul Toxicol Pharmacol. 2004 Apr;39(2):87-98.

PMID:
15041142
10.
11.

Radiation safety program for the cardiac catheterization laboratory.

Chambers CE, Fetterly KA, Holzer R, Lin PJ, Blankenship JC, Balter S, Laskey WK.

Catheter Cardiovasc Interv. 2011 Mar 1;77(4):546-56. doi: 10.1002/ccd.22867. Epub 2011 Jan 19. Review.

PMID:
21254324
12.

Patient safety in the clinical laboratory: a longitudinal analysis of specimen identification errors.

Wagar EA, Tamashiro L, Yasin B, Hilborne L, Bruckner DA.

Arch Pathol Lab Med. 2006 Nov;130(11):1662-8.

PMID:
17076528
13.

Safety and efficacy of buprenorphine for analgesia in laboratory mice and rats.

Guarnieri M, Brayton C, DeTolla L, Forbes-McBean N, Sarabia-Estrada R, Zadnik P.

Lab Anim (NY). 2012 Nov;41(11):337-43. doi: 10.1038/laban.152. Review.

PMID:
23079917
14.

The laboratory and patient safety.

Wagar EA, Yuan S.

Clin Lab Med. 2007 Dec;27(4):909-30, viii-ix. Review.

PMID:
17950905
15.

A double-blind, randomized, placebo/active controlled crossover evaluation of the efficacy and safety of Ritalin ® LA in children with attention-deficit/hyperactivity disorder in a laboratory classroom setting.

Schulz E, Fleischhaker C, Hennighausen K, Heiser P, Oehler KU, Linder M, Haessler F, Huss M, Warnke A, Schmidt M, Schulte-Markworth M, Sieder C, Klatt J, Tracik F.

J Child Adolesc Psychopharmacol. 2010 Oct;20(5):377-85. doi: 10.1089/cap.2009.0106.

PMID:
20973708
16.

'Human-on-a-chip' developments: a translational cutting-edge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man?

Marx U, Walles H, Hoffmann S, Lindner G, Horland R, Sonntag F, Klotzbach U, Sakharov D, Tonevitsky A, Lauster R.

Altern Lab Anim. 2012 Oct;40(5):235-57. Review.

17.

Classifying laboratory incident reports to identify problems that jeopardize patient safety.

Astion ML, Shojania KG, Hamill TR, Kim S, Ng VL.

Am J Clin Pathol. 2003 Jul;120(1):18-26.

20.

Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory.

Jang HJ, Koo BK, Lee HS, Park JB, Kim JH, Seo MK, Yang HM, Park KW, Nam CW, Doh JH, Kim HS.

Eur Heart J. 2013 Jul;34(27):2055-62. doi: 10.1093/eurheartj/eht040. Epub 2013 Feb 8.

Items per page

Supplemental Content

Write to the Help Desk